FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

583311000001106: Viracept 250mg tablets (Roche Products Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16628901000001119 Viracept 250mg tablets (Roche Products Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16629001000001112 Viracept 250mg tablets (Roche Products Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Viracept 250mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Is a Product containing precisely nelfinavir (as nelfinavir mesilate) 250 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Has active ingredient Nelfinavir mesilate false Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Is a Viracept true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Nelfinavir true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Has specific active ingredient Nelfinavir mesilate true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) VMP non-availability indicator Re-introduced false Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) Has basis of strength substance Nelfinavir true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Viracept 250mg tablets (Roche Products Ltd) 300 tablet Is pack of False Viracept 250mg tablets (Roche Products Ltd) Inferred relationship Existential restriction modifier
Viracept 250mg tablets (Roche Products Ltd) 300 tablet Has AMP True Viracept 250mg tablets (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start